•
Jun 30, 2019

iTeos Therapeutics Q2 2019 Earnings Report

EPS
-$0.581
R&D Expenses
$3.9M
G&A Expenses
$2.1M
Gross Profit
$0

iTeos Therapeutics

iTeos Therapeutics